Matthew Paul Kowalsky is CHIEF OF STAFF AND CLO of Sigilon Therapeutics Inc.
Person profile
Roles
Sigilon Therapeutics
CHIEF OF STAFF AND CLO
Address
Marblehead, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ENANTA PHARMACEUTICALS INC
1 May 24
3
ENANTA PHARMACEUTICALS INC
1 May 24
4
Sigilon Therapeutics, Inc.
11 Aug 23
4
Sigilon Therapeutics, Inc.
1 Mar 23
3
Sigilon Therapeutics, Inc.
1 Mar 23
4
PROTEON THERAPEUTICS INC
23 Jan 19
4
PROTEON THERAPEUTICS INC
3 Jan 19
4
PROTEON THERAPEUTICS INC
3 Jul 18
4
PROTEON THERAPEUTICS INC
18 Jan 18
4
PROTEON THERAPEUTICS INC
3 Jan 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Apr 24 | ENTA Enanta Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 13.25 | 150,000 | 1.99 mm | 150,000 |
11 Aug 23 | SGTX Sigilon Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,925 | 0.00 | 0 |
11 Aug 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.75 | 12,690 | 9.52 k | 0 |
28 Feb 23 | SGTX Sigilon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.09 | 165,000 | 179.85 k | 165,000 |